Drugs / NUTROF TOTAL
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04761341 | Jun 2018 → Oct 2019 | age-related macular degeneration | Insel Gruppe AG, University Hospital Bern | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NUTROF TOTAL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04761341 ↗ |
| Route | Oral | “Patients with early and intermediate AMD received oral L and Z supplementation during three months” PMID 37344061 ↗ May 2023 |